Position in QURE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$15,804,383
+$2,842,823 QoQ
Shares Held
343,126
-56.7% QoQ
Ownership
0.544%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#44
of 255 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in QURE Over Time
Shares Held
Position Value (USD)
Derivatives in QURE
reported options exposure · as of Jun 30, 2026CallValue
$9,202,788
CallShares
199,800
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026MILLENNIUM MANAGEMENT LLC holds $4,631,421,099 across 322 Biotechnology names. QURE ranks #63 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
468,410 | $232,673,299 | |
| 2 | INSM |
INSMED Inc
|
2,048,005 | $218,358,293 | |
| 3 | APGE |
Apogee Therapeutics, Inc.
|
1,491,404 | $197,954,052 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
763,880 | $184,072,163 | |
| 5 | ONC |
BeOne Medicines Ltd.
|
543,323 | $154,830,755 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
556,088 | $136,113,659 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
|
2,071,816 | $118,549,311 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
165,120 | $102,958,924 |
All Filings in QURE
Export CSV
31 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,202,788 | 199,800 | Call | Sole | 2026-08-14 | |
| 2026-06-30 | $15,804,383 | 343,126 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $12,961,560 | 792,756 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $717,900 | 30,000 | Put | Sole | 2026-02-17 | |
| 2025-12-31 | $19,230,267 | 803,605 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,751,100 | 30,000 | Put | Sole | 2025-11-14 | |
| 2025-09-30 | $11,183,692 | 191,600 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,849,336 | 132,664 | Shares | Sole | 2025-08-14 | |
| 2025-06-30 | $836,400 | 60,000 | Call | Sole | 2025-08-14 | |
| 2025-03-31 | $339,200 | 32,000 | Call | Sole | 2025-05-15 | |
| 2025-03-31 | $2,816,059 | 265,666 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $8,203,688 | 464,535 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $10,796,606 | 2,189,981 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $2,308,190 | 515,221 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $2,467,810 | 474,579 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $3,083,545 | 455,472 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $2,548,189 | 379,760 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $9,047,692 | 789,502 | Shares | Sole | 2023-08-14 | |
| 2023-06-30 | $2,592,252 | 226,200 | Call | Sole | 2023-08-14 | |
| 2023-03-31 | $7,025,355 | 348,826 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $16,958,520 | 748,060 | Shares | Sole | 2023-02-14 | |
| 2022-06-30 | $2,425,343 | 130,115 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $4,042,042 | 223,688 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $8,164,736 | 393,671 | Shares | Sole | 2022-02-14 | |
| 2021-06-30 | $763,008 | 24,773 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $10,551,539 | 313,195 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $2,250,899 | 62,300 | Call | Sole | 2021-02-16 | |
| 2020-12-31 | $11,613,988 | 321,450 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $707,909 | 19,221 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $12,198,913 | 270,726 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $237,250 | 5,000 | Put | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||